BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 18243182)

  • 1. Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and occult infection.
    Pham TN; King D; Macparland SA; McGrath JS; Reddy SB; Bursey FR; Michalak TI
    Gastroenterology; 2008 Mar; 134(3):812-22. PubMed ID: 18243182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Authentic Patient-Derived Hepatitis C Virus Infects and Productively Replicates in Primary CD4
    Skardasi G; Chen AY; Michalak TI
    J Virol; 2018 Feb; 92(3):. PubMed ID: 29167333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus-specific cellular immune responses in sustained virological responders with viral persistence in peripheral blood mononuclear cells.
    Roque-Cuéllar MC; Sánchez B; García-Lozano JR; Praena-Fernández JM; Márquez-Galán JL; Núñez-Roldán A; Aguilar-Reina J
    Liver Int; 2014 Jul; 34(6):e80-8. PubMed ID: 24127783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occult persistence and lymphotropism of hepatitis C virus infection.
    Pham TN; Michalak TI
    World J Gastroenterol; 2008 May; 14(18):2789-93. PubMed ID: 18473399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonistic expression of hepatitis C virus and alpha interferon in lymphoid cells during persistent occult infection.
    Pham TN; Mulrooney-Cousins PM; Mercer SE; MacParland SA; Inglot M; Zalewska M; Simon K; Michalak TI
    J Viral Hepat; 2007 Aug; 14(8):537-48. PubMed ID: 17650287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naturally occurring resistance mutations within the core and NS5B regions in hepatitis C genotypes, particularly genotype 5a, in South Africa.
    Prabdial-Sing N; Blackard JT; Puren AJ; Mahomed A; Abuelhassan W; Mahlangu J; Vermeulen M; Bowyer SM
    Antiviral Res; 2016 Mar; 127():90-8. PubMed ID: 26704023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
    Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
    J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordant role of CD4 T-cell response relative to neutralizing antibody and CD8 T-cell responses in acute hepatitis C.
    Kaplan DE; Sugimoto K; Newton K; Valiga ME; Ikeda F; Aytaman A; Nunes FA; Lucey MR; Vance BA; Vonderheide RH; Reddy KR; McKeating JA; Chang KM
    Gastroenterology; 2007 Feb; 132(2):654-66. PubMed ID: 17258733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic hepatitis C and persistent occult hepatitis C virus infection are characterized by distinct immune cell cytokine expression profiles.
    Pham TN; Mercer SE; Michalak TI
    J Viral Hepat; 2009 Aug; 16(8):547-56. PubMed ID: 19215578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals.
    Rallón NI; Soriano V; Restrepo C; García-Samaniego J; Labarga P; López M; Peris A; González-Lahoz J; Benito JM
    J Acquir Immune Defic Syndr; 2011 May; 57(1):1-8. PubMed ID: 21786458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus persisting after clinically apparent sustained virological response to antiviral therapy retains infectivity in vitro.
    MacParland SA; Pham TN; Guy CS; Michalak TI
    Hepatology; 2009 May; 49(5):1431-41. PubMed ID: 19177592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid-derived suppressor cells are associated with viral persistence and downregulation of TCR ζ chain expression on CD8(+) T cells in chronic hepatitis C patients.
    Zeng QL; Yang B; Sun HQ; Feng GH; Jin L; Zou ZS; Zhang Z; Zhang JY; Wang FS
    Mol Cells; 2014 Jan; 37(1):66-73. PubMed ID: 24552712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-derived hepatitis C virus inhibits CD4⁺ but not CD8⁺ T lymphocyte proliferation in primary T cells.
    MacParland SA; Chen AY; Corkum CP; Pham TN; Michalak TI
    Virol J; 2015 Jun; 12():93. PubMed ID: 26084511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral blood neutrophils from hepatitis C virus-infected patients are replication sites of the virus.
    Crovatto M; Pozzato G; Zorat F; Pussini E; Nascimben F; Baracetti S; Grando MG; Mazzaro C; Reitano M; Modolo ML; Martelli P; Spada A; Santini G
    Haematologica; 2000 Apr; 85(4):356-61. PubMed ID: 10756359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of HCV co-infection with occult hepatitis B virus in patients undergoing IFN therapy.
    Khattab E; Chemin I; Vuillermoz I; Vieux C; Mrani S; Guillaud O; Trepo C; Zoulim F
    J Clin Virol; 2005 Jun; 33(2):150-7. PubMed ID: 15911431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low level or absent in vivo replication of hepatitis C virus and hepatitis G virus/GB virus C in peripheral blood mononuclear cells.
    Mellor J; Haydon G; Blair C; Livingstone W; Simmonds P
    J Gen Virol; 1998 Apr; 79 ( Pt 4)():705-14. PubMed ID: 9568964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of pegylated interferon plus ribavirin in chronic hepatitis C patients with occult hepatitis B virus dual infection.
    Chen LW; Chien RN; Yen CL; Chang JJ; Liu CJ; Lin CL
    J Gastroenterol Hepatol; 2010 Feb; 25(2):259-63. PubMed ID: 19817959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Occult Hepatitis C Virus Infection in Patients Who Achieved a Sustained Virologic Response to Direct-Acting Antiviral Agents for Recurrent Infection After Liver Transplantation.
    Elmasry S; Wadhwa S; Bang BR; Cook L; Chopra S; Kanel G; Kim B; Harper T; Feng Z; Jerome KR; Kahn JA; Saito T
    Gastroenterology; 2017 Feb; 152(3):550-553.e8. PubMed ID: 27838287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project).
    Pilli M; Zerbini A; Penna A; Orlandini A; Lukasiewicz E; Pawlotsky JM; Zeuzem S; Schalm SW; von Wagner M; Germanidis G; Lurie Y; Esteban JI; Haagmans BL; Hezode C; Lagging M; Negro F; Homburger Y; Neumann AU; Ferrari C; Missale G;
    Gastroenterology; 2007 Oct; 133(4):1132-43. PubMed ID: 17919489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signatures of protective memory immune responses during hepatitis C virus reinfection.
    Abdel-Hakeem MS; Bédard N; Murphy D; Bruneau J; Shoukry NH
    Gastroenterology; 2014 Oct; 147(4):870-881.e8. PubMed ID: 25038432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.